PSEC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Price is sitting on/near support (~2.72) but momentum is still weakening (bearish MACD expansion) and there’s no proprietary buy signal today (no AI Stock Picker, no SwingMax). With sharp YoY deterioration in the latest reported quarter and no fresh news catalyst ahead of earnings (2026-02-09), the risk/reward is not attractive for an impatient buyer looking for immediate upside—avoid buying here.
Trend/momentum: Bearish-to-weak. MACD histogram is negative (-0.0114) and expanding lower, signaling downside momentum is strengthening. RSI(6)=38.745 is not oversold, so there’s room for further downside before a technical “snap-back” is statistically favored. Moving averages are converging (no strong trend confirmation), which often precedes a larger move; with MACD negative, the bias remains downward. Key levels: Current price 2.7236 is essentially at S1=2.722. If S1 fails, next support is S2=2.649. Overhead resistance starts at Pivot=2.841, then R1=2.959. Near-term setup: a possible support bounce exists, but it’s not confirmed (momentum still deteriorating) and there’s no Intellectia buy trigger to prioritize.
Intellectia Proprietary Trading Signals
Insiders are buying (purchase amount up 149.74% over the last month), which is a supportive signal. Price is at a defined support zone (2.72), so a short technical bounce is possible if support holds. Earnings are upcoming (QDec 2025, reported 2026-02-09 after hours), which could act as a catalyst if results or guidance surprise positively.
No recent news flow to spark an upside re-rating in the near term. The latest quarter shows severe YoY declines in revenue, net income, and EPS (fundamental pressure). No Intellectia proprietary buy signals today to justify prioritizing an entry for a fast move.
Latest quarter: 2026/Q1. Reported performance shows sharp YoY deterioration: Revenue 156.332M (down -661.76% YoY), Net Income 48.087M (down -129.13% YoY), EPS 0.08 (down -121.05% YoY). Gross margin is listed at 98.61% (flat YoY). Overall read: the snapshot indicates weakening profitability and earnings power versus last year, which typically caps upside and raises downside risk into/around the next earnings event (2026-02-09).
No analyst rating or price target change data was provided, so a recent trend cannot be verified here. Wall Street-style pros/cons based on available data: Pros—insider buying and mildly bullish options skew. Cons—deteriorating quarterly YoY fundamentals and weakening technical momentum near support, with no confirmed proprietary buy signals.
